Загрузка...
Effect of Maraviroc on HIV Disease Progression-Related Biomarkers
The potential effect of blocking the CCR5 receptor on HIV disease progression biomarkers is not well understood. We showed that an 8-day maraviroc (MVC) monotherapy clinical test (MCT) can be used in selecting patients to receive MVC-containing combined antiretroviral therapy (cART). Using this MCT...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3486555/ https://ncbi.nlm.nih.gov/pubmed/22948867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01406-12 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|